Published in Circulation on December 01, 1996
Managing preexisting diabetes for pregnancy: summary of evidence and consensus recommendations for care. Diabetes Care (2008) 2.04
Tibial artery calcification as a marker of amputation risk in patients with peripheral arterial disease. J Am Coll Cardiol (2008) 1.85
Lower extremity peripheral artery disease in the absence of traditional risk factors. The Multi-Ethnic Study of Atherosclerosis. Atherosclerosis (2010) 1.71
Calf muscle perfusion at peak exercise in peripheral arterial disease: measurement by first-pass contrast-enhanced magnetic resonance imaging. J Magn Reson Imaging (2007) 1.54
Epidemiology, classification, and modifiable risk factors of peripheral arterial disease. Vasc Health Risk Manag (2007) 1.51
Patterns of ambulatory activity in subjects with and without intermittent claudication. J Vasc Surg (2007) 1.47
Cell therapy of peripheral arterial disease: from experimental findings to clinical trials. Circ Res (2013) 1.43
Delayed calf muscle phosphocreatine recovery after exercise identifies peripheral arterial disease. J Am Coll Cardiol (2006) 1.35
Plasma levels of soluble Tie2 and vascular endothelial growth factor distinguish critical limb ischemia from intermittent claudication in patients with peripheral arterial disease. J Am Coll Cardiol (2008) 1.22
Atherosclerotic risk factor reduction in peripheral arterial diseasea: results of a national physician survey. J Gen Intern Med (2002) 1.19
The morbidity and mortality following a diagnosis of peripheral arterial disease: long-term follow-up of a large database. BMC Cardiovasc Disord (2005) 1.18
Depressive symptoms and lower extremity functioning in men and women with peripheral arterial disease. J Gen Intern Med (2003) 1.16
Calf muscle hemoglobin oxygen saturation characteristics and exercise performance in patients with intermittent claudication. J Vasc Surg (2008) 1.10
Genetic susceptibility to peripheral arterial disease: a dark corner in vascular biology. Arterioscler Thromb Vasc Biol (2007) 1.09
Gender and ethnic differences in arterial compliance in patients with intermittent claudication. J Vasc Surg (2010) 1.04
Peripheral arterial disease in the elderly. Clin Interv Aging (2007) 1.03
Sex differences in calf muscle hemoglobin oxygen saturation in patients with intermittent claudication. J Vasc Surg (2009) 1.03
Physical activity is a predictor of all-cause mortality in patients with intermittent claudication. J Vasc Surg (2008) 1.01
The effect of metabolic syndrome components on exercise performance in patients with intermittent claudication. J Vasc Surg (2008) 1.00
Gender differences in daily ambulatory activity patterns in patients with intermittent claudication. J Vasc Surg (2010) 0.98
Hemodynamic influences on abdominal aortic aneurysm disease: Application of biomechanics to aneurysm pathophysiology. Vascul Pharmacol (2010) 0.95
Exercise performance in patients with peripheral arterial disease who have different types of exertional leg pain. J Vasc Surg (2007) 0.92
DVC1-0101 to treat peripheral arterial disease: a Phase I/IIa open-label dose-escalation clinical trial. Mol Ther (2013) 0.91
Multiparametric assessment of vascular function in peripheral artery disease: dynamic measurement of skeletal muscle perfusion, blood-oxygen-level dependent signal, and venous oxygen saturation. Circ Cardiovasc Imaging (2015) 0.89
Angiogenic factor AGGF1 promotes therapeutic angiogenesis in a mouse limb ischemia model. PLoS One (2012) 0.89
Peripheral arterial disease of the lower extremities. Arch Med Sci (2012) 0.89
Critical review of the ankle brachial index. Curr Cardiol Rev (2008) 0.89
Walking economy before and after the onset of claudication pain in patients with peripheral arterial disease. J Vasc Surg (2010) 0.88
Prevalence and risk factors of asymptomatic peripheral arterial disease in patients with COPD in Taiwan. PLoS One (2013) 0.88
Peripheral arterial disease: a high risk - but neglected - disease population. BMC Cardiovasc Disord (2005) 0.87
Vildagliptin stimulates endothelial cell network formation and ischemia-induced revascularization via an endothelial nitric-oxide synthase-dependent mechanism. J Biol Chem (2014) 0.86
Unacylated ghrelin promotes skeletal muscle regeneration following hindlimb ischemia via SOD-2-mediated miR-221/222 expression. J Am Heart Assoc (2013) 0.86
The influence of obesity on calf blood flow and vascular reactivity in older adults. Dyn Med (2007) 0.85
Sex difference in the association of metabolic syndrome with high sensitivity C-reactive protein in a Taiwanese population. BMC Public Health (2010) 0.85
Peripheral artery disease in patients with diabetes: Epidemiology, mechanisms, and outcomes. World J Diabetes (2015) 0.84
Insights Into Microcirculation Underlying Critical Limb Ischemia by Single-Photon Emission Computed Tomography. Medicine (Baltimore) (2015) 0.83
Ultrahigh sensitive optical microangiography reveals depth-resolved microcirculation and its longitudinal response to prolonged ischemic event within skeletal muscles in mice. J Biomed Opt (2011) 0.83
Skeletal muscle perfusion in peripheral arterial disease a novel end point for cardiovascular imaging. JACC Cardiovasc Imaging (2008) 0.83
Clinical application of vascular regenerative therapy for peripheral artery disease. Biomed Res Int (2013) 0.83
Abdominal aortic aneurysm in patients affected by intermittent claudication: prevalence and clinical predictors. BMC Surg (2012) 0.83
Vascular calcification in patients with nondialysis CKD over 3 years. Clin J Am Soc Nephrol (2015) 0.83
Increased prevalence of peripheral arterial disease in osteoporotic postmenopausal women. J Bone Miner Metab (2006) 0.82
Incidence of and factors associated with achieving target lipid levels in patients with peripheral arterial disease. J Gen Intern Med (2006) 0.82
Endovascular treatment of lower extremity arteries is associated with an improved outcome in diabetic patients affected by intermittent claudication. BMC Surg (2012) 0.81
The relation of metabolic syndrome according to five definitions to cardiovascular risk factors--a population-based study. BMC Public Health (2009) 0.81
Association between daily ambulatory activity patterns and exercise performance in patients with intermittent claudication. J Vasc Surg (2008) 0.81
Methods of symptom evaluation and their impact on peripheral artery disease (PAD) symptom prevalence: a review. Vasc Med (2013) 0.81
Ankle/brachial index to everyone. BMC Surg (2012) 0.80
Peripheral arterial stiffness is independently associated with a rapid decline in estimated glomerular filtration rate in patients with type 2 diabetes. Biomed Res Int (2013) 0.80
Dietary intake of participants with peripheral artery disease and claudication. Angiology (2011) 0.80
Cardiovascular responses to walking in patients with peripheral artery disease. Med Sci Sports Exerc (2011) 0.80
Low-intensity resistance exercise does not affect cardiac autonomic modulation in patients with peripheral artery disease. Clinics (Sao Paulo) (2013) 0.79
Public private partnership in vascular surgery. Einstein (Sao Paulo) (2014) 0.79
Quantitative optical imaging of vascular response in vivo in a model of peripheral arterial disease. Am J Physiol Heart Circ Physiol (2013) 0.79
Plantar flexion training primes peripheral arterial disease patients for improvements in cardiac function. Eur J Appl Physiol (2009) 0.78
Ethnic differences in ankle brachial index are present in middle-aged individuals without peripheral arterial disease. Int J Cardiol (2011) 0.78
Plantar flexion: an effective training for peripheral arterial disease. Eur J Appl Physiol (2008) 0.78
Sedentary behavior is associated with impaired biomarkers in claudicants. J Vasc Surg (2015) 0.77
Resting energy expenditure in subjects with and without intermittent claudication. Metabolism (2009) 0.77
Far red/near infrared light treatment promotes femoral artery collateralization in the ischemic hindlimb. J Mol Cell Cardiol (2013) 0.77
Clinical predictors of ventilatory threshold achievement in patients with claudication. Med Sci Sports Exerc (2015) 0.77
Effects of age, sex and smoking on ankle-brachial index in a Finnish population at risk for cardiovascular disease. Int J Angiol (2007) 0.77
Risks of decreased renal function and increased albuminuria for glycemic status and metabolic syndrome components: Taichung Community Health study. Biomed Res Int (2014) 0.76
V.O2 Kinetics and clinical factors among patients with peripheral artery disease. J Cardiopulm Rehabil Prev (2013) 0.76
Comparison of beraprost and ticlopidine in Chinese patients with chronic peripheral arterial occlusion: a multicenter, single-blind, randomized, controlled study. Curr Ther Res Clin Exp (2003) 0.76
Liposome-based vascular endothelial growth factor-165 transfection with skeletal myoblast for treatment of ischaemic limb disease. J Cell Mol Med (2008) 0.76
Community-based walking exercise for peripheral artery disease: An exploratory pilot study. Vasc Med (2015) 0.76
(2-Hydroxypropyl)-β-Cyclodextrin Is a New Angiogenic Molecule for Therapeutic Angiogenesis. PLoS One (2015) 0.76
Asthma Is Associated With a Subsequent Risk of Peripheral Artery Disease: A Longitudinal Population-Based Study. Medicine (Baltimore) (2016) 0.76
Vascular quality of care pilot study: how admission to a vascular surgery service affects evidence-based pharmacologic risk factor modification in patients with lower extremity peripheral arterial disease. Vasc Health Risk Manag (2014) 0.75
Peripheral arterial disease, type 2 diabetes and postprandial lipidaemia: Is there a link? World J Diabetes (2014) 0.75
A single bout of resistance exercise does not modify cardiovascular responses during daily activities in patients with peripheral artery disease. Blood Press Monit (2014) 0.75
LDL lowering in peripheral arterial disease: are there benefits beyond reducing cardiovascular morbidity and mortality? Clin Lipidol (2012) 0.75
Reduced high-density lipoprotein level is linked to worse ankle brachial index and peak oxygen uptake in postmenopausal women with peripheral arterial disease. Angiology (2010) 0.75
Outcomes of infrainguinal bypass determined by age in the Vascular Study Group of New England. J Vasc Surg (2015) 0.75
Topical Administration of Pirfenidone Increases Healing of Chronic Diabetic Foot Ulcers: A Randomized Crossover Study. J Diabetes Res (2016) 0.75
Non-invasive cardiac assessment in high risk patients (The GROUND study): rationale, objectives and design of a multi-center randomized controlled clinical trial. Trials (2008) 0.75
Serum N-terminal pro-B-type natriuretic peptide levels are associated with functional capacity in patients with peripheral arterial disease. Angiology (2011) 0.75
Validation of a Brazilian Portuguese Version of the Walking Estimated-Limitation Calculated by History (WELCH). Arq Bras Cardiol (2015) 0.75
Preventing and detecting early vascular effects of diabetes: word of caution on peripheral arterial assessment. BMJ (2006) 0.75
Therapy for peripheral artery disease: gaps in treating patients with claudication. Circulation (2014) 0.75
High Systolic and Diastolic Blood Pressure Variability Is Correlated with the Occurrence of Peripheral Arterial Disease in the First Decade following a Diagnosis of Type 2 Diabetes Mellitus: A New Biomarker from Old Measurement. Biomed Res Int (2016) 0.75
Clinical significance of ankle systolic blood pressure following exercise in assessing calf muscle tissue ischemia in peripheral artery disease. Angiology (2012) 0.75
The fate of patients with intermittent claudication in the 21st century revisited - results from the CAVASIC Study. Sci Rep (2017) 0.75
Contemporary evaluation and management of the diabetic foot. Scientifica (Cairo) (2012) 0.75
Factors Associated with Sedentary Behavior in Patients with Intermittent Claudication. Eur J Vasc Endovasc Surg (2016) 0.75
Is asymptomatic peripheral arterial disease associated with walking endurance in patients with COPD? Int J Chron Obstruct Pulmon Dis (2015) 0.75
Long-Term Outcomes and Causes of Death in Patients With Renovascular Disease Undergoing Renal Artery Stenting. Angiology (2015) 0.75
Rationale and Design of Randomized Clinical Trial for the Assessment of Macitentan Efficiency as Coadjuvant Treatment to Open and Endovascular Revascularization in Critical Limb Ischemia. Clin Med Insights Cardiol (2016) 0.75
Supervised and home-based exercise training for patients with intermittent claudication. Int J Angiol (2008) 0.75
Factors associated with lower extremity atherosclerotic disease in Chinese patients with type 2 diabetes mellitus: A case-control study. Medicine (Baltimore) (2016) 0.75
Impact of a bidirectional approach via radial and popliteal arteries for the treatment of chronic total occlusion of lower limb artery: A case report. Int J Angiol (2007) 0.75
Validity and reliability of the ankle-brachial index by oscillometric blood pressure and automated ankle-brachial index. J Res Med Sci (2017) 0.75
Femoral Artery Atherosclerosis Is Associated With Physical Function Across the Spectrum of the Ankle-Brachial Index: The San Diego Population Study. J Am Heart Assoc (2017) 0.75
Evidence based medicine: what it is and what it isn't. BMJ (1996) 66.70
Inpatient general medicine is evidence based. A-Team, Nuffield Department of Clinical Medicine. Lancet (1995) 24.14
Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med (1991) 18.33
The Burlington randomized trial of the nurse practitioner. N Engl J Med (1974) 17.02
Bias in analytic research. J Chronic Dis (1979) 16.40
A controlled trial of teaching critical appraisal of the clinical literature to medical students. JAMA (1987) 14.20
The number needed to treat: a clinically useful measure of treatment effect. BMJ (1995) 13.89
An assessment of clinically useful measures of the consequences of treatment. N Engl J Med (1988) 13.02
Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med (1998) 11.27
Increased absenteeism from work after detection and labeling of hypertensive patients. N Engl J Med (1978) 9.29
Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials. Lancet (2013) 8.16
Controversy in the detection of disease. Lancet (1975) 7.85
How to keep up with the medical literature: V. Access by personal computer to the medical literature. Ann Intern Med (1986) 7.36
Controversy in counting and attributing events in clinical trials. N Engl J Med (1979) 7.25
Randomised clinical trial of strategies for improving medication compliance in primary hypertension. Lancet (1975) 7.22
Users' guides to the medical literature. I. How to get started. The Evidence-Based Medicine Working Group. JAMA (1993) 6.83
A utility maximization model for evaluation of health care programs. Health Serv Res (1972) 6.67
Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg (1997) 5.88
Prevention of venous thromboembolism. Chest (2001) 5.59
Paclitaxel-resistant human ovarian cancer cells have mutant beta-tubulins that exhibit impaired paclitaxel-driven polymerization. J Biol Chem (1997) 5.51
Users' guides to the medical literature. IX. A method for grading health care recommendations. Evidence-Based Medicine Working Group. JAMA (1995) 5.28
Problems in the handling of clinical and research evidence by medical practitioners. Arch Intern Med (1983) 5.16
A randomized trial of continuing medical education. N Engl J Med (1982) 4.95
Improvement of medication compliance in uncontrolled hypertension. Lancet (1976) 4.84
The Burlington randomized trial of the nurse practitioner: health outcomes of patients. Ann Intern Med (1974) 4.37
The utility of different health states as perceived by the general public. J Chronic Dis (1978) 3.65
An empirical demonstration of Berkson's bias. J Chronic Dis (1978) 3.48
Limitations of impedance plethysmography in the diagnosis of clinically suspected deep-vein thrombosis. Ann Intern Med (1993) 3.40
The North American Symptomatic Carotid Endarterectomy Trial : surgical results in 1415 patients. Stroke (1999) 3.31
Can simple clinical measurements detect patient noncompliance? Hypertension (1981) 3.29
Complement receptor type three (CD11b/CD18) of human polymorphonuclear leukocytes recognizes fibrinogen. Proc Natl Acad Sci U S A (1988) 3.25
Rules of evidence and clinical recommendations on the use of antithrombotic agents. Chest (1986) 3.16
p53 is associated with cellular microtubules and is transported to the nucleus by dynein. Nat Cell Biol (2000) 3.05
Does a mailed continuing education program improve physician performance? Results of a randomized trial in antihypertensive care. JAMA (1986) 3.04
Choosing the best research design for each question. BMJ (1998) 3.03
Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal-vein thrombosis. N Engl J Med (1986) 3.00
The measurement iterative loop: a framework for the critical appraisal of need, benefits and costs of health interventions. J Chronic Dis (1985) 2.96
How to keep up with the medical literature: I. Why try to keep up and how to get started. Ann Intern Med (1986) 2.94
Quality-of-care appraisal in primary care: a quantitative method. Ann Intern Med (1975) 2.87
Definition of osteoarthritis of the knee for epidemiological studies. Ann Rheum Dis (1993) 2.83
Rules of evidence and clinical recommendations on the use of antithrombotic agents. Chest (1992) 2.81
Unfractionated heparin and low-molecular-weight heparin in acute coronary syndrome without ST elevation: a meta-analysis. Lancet (2000) 2.74
Concern about safety of carotid angioplasty. Stroke (1996) 2.73
Centrosome amplification and instability occurs exclusively in aneuploid, but not in diploid colorectal cancer cell lines, and correlates with numerical chromosomal aberrations. Genes Chromosomes Cancer (2000) 2.73
Methodologic guidelines for systematic reviews of randomized control trials in health care from the Potsdam Consultation on Meta-Analysis. J Clin Epidemiol (1995) 2.73
Prevention of venous thromboembolism. Chest (1995) 2.69
Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer. J Natl Cancer Inst (1998) 2.67
Ultrasonic flow detection. A useful technic in the evaluation of peripheral vascular disease. Am J Surg (1967) 2.63
The development and application of indices of health: general methods and a summary of results. Am J Public Health (1977) 2.53
Clinical recommendations using levels of evidence for antithrombotic agents. Chest (1995) 2.52
Pathophysiology of tissue fluid. Proc R Soc Med (1972) 2.46
Using research findings in clinical practice. BMJ (1998) 2.40
The rational clinical examination. Does this patient have splenomegaly? JAMA (1993) 2.38
The rational clinical examination. Does this patient have a clinically important carotid bruit? JAMA (1993) 2.38
Hypertension in a family practice. Can Med Assoc J (1977) 2.36
Sex differences in evaluation and outcome of unstable angina. JAMA (2000) 2.33
Evaluation of mental retardation: recommendations of a Consensus Conference: American College of Medical Genetics. Am J Med Genet (1997) 2.19
New insights into the link between cardiovascular disease and depression. Int J Clin Pract (2007) 2.18
Raynaud syndrome. Semin Arthritis Rheum (1981) 2.17
Classical pituitary apoplexy: clinical features, management and outcome. Clin Endocrinol (Oxf) (1999) 2.15
Rapid HPLC determination of total homocysteine and other thiols in serum and plasma: sex differences and correlation with cobalamin and folate concentrations in healthy subjects. Clin Chem (1994) 2.14
Rules of evidence and clinical recommendations for the management of patients. Can J Cardiol (1993) 2.11
When was a "negative" clinical trial big enough? How many patients you needed depends on what you found. Arch Intern Med (1985) 2.11
Transferring evidence from research into practice: 1. The role of clinical care research evidence in clinical decisions. ACP J Club (1996) 2.10
Homocysteine-induced endoplasmic reticulum stress and growth arrest leads to specific changes in gene expression in human vascular endothelial cells. Blood (1999) 2.08
Anglo-French contrasts in medical practice. Br Med J (1980) 2.07
Real-world variability in dabigatran levels in patients with atrial fibrillation. J Thromb Haemost (2015) 2.07
Cost effectiveness of clinical diagnosis, venography, and noninvasive testing in patients with symptomatic deep-vein thrombosis. N Engl J Med (1981) 2.04
Guidelines for managing raised blood pressure. BMJ (1996) 2.03
Management of suspected deep venous thrombosis in outpatients by using clinical assessment and D-dimer testing. Ann Intern Med (2001) 1.93
A novel and rapid whole-blood assay for D-dimer in patients with clinically suspected deep vein thrombosis. Circulation (1995) 1.90
Proposed diagnostic criteria for apathy in Alzheimer's disease and other neuropsychiatric disorders. Eur Psychiatry (2009) 1.86
Cardiovascular diseases. Lancet (1974) 1.85
Pentoxifylline efficacy in the treatment of intermittent claudication: multicenter controlled double-blind trial with objective assessment of chronic occlusive arterial disease patients. Am Heart J (1982) 1.82
An electrically calibrated plethysmograph for direct measurement of limb blood flow. IEEE Trans Biomed Eng (1975) 1.82
Prevention of venous thromboembolism. Chest (1992) 1.81
Risk of atrophy in kidneys with atherosclerotic renal artery stenosis. Kidney Int (1998) 1.81
Apolipoprotein E4 and Alzheimer's disease pathology in Lewy body disease and in other beta-amyloid-forming diseases. Lancet (1994) 1.78
Fenoterol and fatal asthma. Lancet (1990) 1.77
Educational attainment in long-term survivors of childhood acute lymphoblastic leukemia. JAMA (1994) 1.76
Characterization of a mouse model for thrombomodulin deficiency. Arterioscler Thromb Vasc Biol (2001) 1.76
Labelling in hypertension: a review of the behavioural and psychological consequences. J Chronic Dis (1984) 1.75
How to keep up with the medical literature: IV. Using the literature to solve clinical problems. Ann Intern Med (1986) 1.75
Comparison of three-factor and four-factor prothrombin complex concentrates regarding reversal of the anticoagulant effects of rivaroxaban in healthy volunteers. J Thromb Haemost (2014) 1.74
Cochrane Collaboration. BMJ (1994) 1.74